20-30% of prescriptions will never be filled (see: https://www.ncbi.nlm.nih.gov/pubmed/22964778 ). The stats may be higher for SAS products such as medicinal cannabis.
The good news is that even if we’re assuming a 50% fill rate, that’s still pretty decent income for MXC. We’re on the right track people!
Ann: 800 Prescription Milestone Passed for MGC Pharma Products, page-28
-
- There are more pages in this discussion • 106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.120(42.1%) |
Mkt cap ! $7.986M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 25.5¢ | 15.0¢ | $58.44K | 348.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15540 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 7113 | 3 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| RGT (ASX) Chart |